Ca2+ overload and mitochondrial permeability transition pore activation in living delta-sarcoglycan-deficient

Bodvaël Fraysse1, Sadia M Nagi, Belinda Boher

  • 1Institut de Myologie-UPMC, INSERM U974, CNRS, Paris, France.

Insights

Cardiomyopathy in delta-sarcoglycan deficiency involves increased cell calcium. This calcium overload triggers cardiomyocyte death via mitochondrial dysfunction and necrosis, not apoptosis or autophagy.

Area of Science:

  • Cardiovascular Biology
  • Cellular Biology
  • Muscle Diseases

Background:

  • Muscular dystrophies frequently present with cardiac complications, notably cardiomyopathy.
  • Sarcoglycan gene mutations are linked to prominent cardiac dysfunction.
  • The precise mechanisms of cardiomyocyte death in sarcoglycan deficiency remain incompletely understood.

Purpose of the Study:

  • To investigate the role of cytosolic calcium (Ca2+) increase in cardiomyocyte death.
  • To test the hypothesis that Ca2+ overload leads to mitochondrial dysfunction and cell death in delta-sarcoglycan deficient hamsters.
  • To elucidate the specific pathways involved in cardiomyocyte death.

Main Methods:

  • Utilized Fura-2 and Rhod-2 fluorescent probes to measure cytosolic and mitochondrial Ca2+ levels.
  • Employed Mito-Tracker red and transmission electron microscopy to assess mitochondrial morphology.
  • Analyzed mitochondrial permeability transition pore (MPTP) activity and reactive oxygen species (ROS) production.
  • Examined expression of apoptosis (Bax, Bcl-2) and autophagy (LC3) markers via Western blot.

Main Results:

  • Elevated cytosolic and mitochondrial Ca2+ levels were observed in delta-sarcoglycan deficient cardiomyocytes.
  • Approximately 15% of deficient cardiomyocytes showed disorganized mitochondria with swelling and membrane disruption.
  • Mitochondria from deficient cells exhibited twofold higher MPTP activity; ROS production remained unchanged.
  • Apoptosis and autophagy pathways were not significantly activated in the affected hearts.

Conclusions:

  • Cardiomyocyte death in delta-sarcoglycan deficiency is an intrinsic process.
  • Calcium overload-induced mitochondrial dysfunction and MPTP activation are key contributors to necrosis.
  • Mitochondrial disorganization plays a significant role in this Ca2+-induced cell death pathway.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...